Medicine was built to fix what breaks. Now the goal creeps past normal toward better-than-well — reframing health as a performance to maximize, and raising the question of who gets to be enhanced.
Change driver · Updated July 2026
The shift ahead
Medicine has always aimed at a target called normal — restore function, return to baseline, get better. The change is that normal is no longer the finish line.
A treatment for a hormone deficiency gets sold to healthy men as an upgrade. A tech founder spends millions engineering his body past every benchmark. A funded competition invites athletes to chase records on drugs the rest of sport bans. The aim is sliding from fixing what is wrong toward maximizing what is already fine.
The shift is not wellness culture writ large. It is the movement of health from repair toward enhancement — where the line between treating a problem and upgrading a healthy body gets harder to find, and harder to police.
Why it matters
Once better-than-well is for sale, health starts to look less like a right and more like a competition.
As long as medicine aimed at normal, it had a natural stopping point: you were treated until you were well. Enhancement has no such ceiling. There is always another marker to improve, another edge to buy — which turns health into an open-ended project, and a status game, rather than a state you can reach.
That reshapes markets, medicine and fairness at once. It pulls doctors and drugs toward serving the healthy and wealthy, medicalizes ordinary aging and difference and opens a gap between the enhanced and the rest. When advantage can be purchased and installed, the old idea of a level playing field starts to look quaint.
The goal shifts from restoring health to maximizing it, treating a well body as something to be pushed further.
Tech founder Bryan Johnson spends about $2 million a year measuring and optimizing every organ to become “the healthiest human alive” — though most of the benefit, studies suggest, comes from the free basics of sleep, diet and exercise.
Legitimate treatments get marketed to healthy people as upgrades, blurring the line between therapy and enhancement inside the clinic.
US testosterone prescriptions have surged as telehealth clinics and influencers rebrand a treatment for medical deficiency into a performance ‘biohack’ and lifestyle upgrade — enhancement sold as medicine, well beyond its approved use.
As enhancement becomes buyable, competition and society have to decide what an unaltered body is even worth.
The Enhanced Games, backed by Peter Thiel, built a competition that lets athletes use banned performance-enhancing drugs — testosterone, steroids, growth hormone — which the head of US Anti-Doping called a dangerous clown show.
Right now, the line between healing and enhancing is dissolving faster than anyone is redrawing it.
You can see it in performance clinics, in optimization protocols, in enhancement moving from the fringe into ordinary consumer life. Some of it genuinely helps people feel and function better. Some of it medicalizes normal life, sells advantage to those who can pay and leaves everyone else feeling deficient by comparison.
The line that matters is the line between health as care and health as competition. The stronger version widens access to real improvement without turning wellbeing into a race. The weaker version makes better-than-well a product, and quietly resets the baseline so that being merely healthy starts to feel like falling behind.
Watch when the goal stops being normal and starts being more.
The driver strengthens as optimization, enhancement and performance medicine move from niche into mainstream markets, clinics and culture. It strengthens each time a treatment meant to fix something is sold to someone with nothing wrong, and each time an advantage that used to be earned can simply be bought.
The question is not whether people will always want to be better. They will. The question is whether enhancement is offered to everyone or sold to a few — and what happens to a society that treats a healthy body as merely a starting point.
We track the ones that will reshape your field, and what to do about them.